bg-rf.org.uk Report : Visit Site

Technical data of the bg-rf.org.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host bg-rf.org.uk. Currently, hosted in United States and its service provider is Fastly .

the related websites

cmegroup.com oprah.com here-be-dreams.com askbaby.com lipomaboard.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called openresty containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

home about us what we do staff book publications news videos podcast 2018 initiatives contacts donate prevent. restore. preserve. we use the power of science to alleviate suffering through preventive and restorative medicine learn more contribute in collaboration with meet us the business of longevity 2017 health innovation for an ageing world october 27th 2017 | hong kong register ft global pharmaceutical and biotechnology conference thriving amid uncertainty london | 09 - 10 november 2017 register our latest publications all publications november 15, 2017 towards natural mimetics of metformin and rapamycin november 9, 2017 converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare 28 september, 2017 induced cell turnover: a novel therapeutic modality for in situ tissue regeneration our latest news all press may 3, 2018 longevity industry landscape overview volume ii: “the business of longevity” february 2, 2018 longevity industry systematized for first time december 1, 2017 bgrf and sils scientists analyze viability of shrna therapy for huntington's disease our latest videos all videos october 6, 2017 the science of living longer - richard faragher october 4, 2017 jim mellon: why you will live to 120 september 29, 2017 jim mellon talks about juvenescence activities funding research to develop interventions which remediate the molecular damage underlying the diseases of ageing public outreach and advocacy for ageing research evaluating the impact of biomedical discoveries on the economy hosting seminars and conferences encouraging young scientists to specialize in the areas of biogerontology acting as a think tank for ageing research policy establishing strategic partnerships to galvanize progress in biomedical gerontology what we do the objective of research conducted or funded by the biogerontology research foundation (the bgrf) is to produce effective cures or treatments for the diseases and frailty commonly associated with ageing in the human population learn more board of trustees dmitry kaminsky managing trustee joão pedro de magalhães trustee jim plante trustee richard faragher trustee jim mellon trustee dmitry kaminsky managing trustee dmitry kaminskiy is a new generation entrepreneur and well-known visionary originally from eastern europe. he has been concentrating on developing his business in east asia as a priority in recent years. dmitry built his wealth on it-solutions, analytics and predictions for private banking, financial engineering and rapidly growing industries. he is known for his experience in information technology, advanced computer science and development of advanced big data industrial expert analytical systems. he has a wide network spanning the scientific and business communities across the globe.inspired by breakthrough antiaging research dmitry decided to apply his high-level computer developing infrastructure to analyze complex unstructured big data in biomedicine and longevity in particular to find a real breakthrough therapies to treat age-related diseases and prolong active and productive longevity.becoming a trustee of the biogerontology research foundation (bgrf) in london, founded in 2007, was the logical next step of his mission. bgrf supports research on aging, addressing the challenges of a rapidly aging population. their research was aimed to reduce the impact of age-related diseases on future generations. joão pedro de magalhães trustee dr de magalhaes, a trustee of the biogerontology research foundation, graduated in microbiology in 1999 from the escola superior de biotecnologia in his hometown of porto, portugal, and then obtained his phd in 2004 from the university of namur in belgium, where he worked in the ageing and stress group led by dr olivier toussaint. following a postdoc with genomics pioneer prof george church at harvard medical school in boston, usa, in 2008 dr de magalhaes was recruited to the university of liverpool in the uk to develop his own group on genomic approaches to ageing. now a senior lecturer, dr de magalhaes leads the integrative genomics of ageing group (http://pcwww.liv.ac.uk/~aging/) which focuses on understanding the genetic, cellular, and molecular mechanisms of ageing. the group’s research integrates different strategies, but its focal point is developing and applying experimental and computational methods that help bridge the gap between genotype and phenotype, a major challenge of the post-genome era, and help decipher the human genome and how it regulates complex processes like ageing. notably, his group is a world-leader in employing genomics and bioinformatics to study ageing with pioneering work in studying gene networks of ageing and in sequencing and analyzing genomes from long-lived species. dr de magalhaes has given over 100 invited talks, including a tedx talk, and his research has been widely featured in the popular press (bbc, cnn, the washington post, the financial times and many others). jim plante trustee jim plante is the founder, chief executive officer and chairman of the board of klotho therapeutics , a potentially life-changing biotechnology company that is focused on developing the naturally occurring human protein known as klotho. this protein has shown a major potential for increased longevity kidney function and cognition. the klotho protein has the potential to delay the symptoms of aging and disease. the protein can potentially slow down the progression of diabetes, cancer and kidney disease. klotho therapeutics is using biotechnology to produce a synthetic human protein that mimics the klotho protein and doing research to help bring it to market. jim plante is also the founder, chairman of the board and former ceo of the healthcare company pathway genomics . this revolutionary company began with the goal of providing affordable medications and genetic testing to the public. pathway provides a variety of testing services for conditions that include cardiac health, hereditary cancer risk, nutrition and exercise response and inherited diseases. the company also compiles profiles for patients regarding their responses to some of the more commonly prescribed prescription medications. along with pathway genomics, jim currently manages twelve companies under thynk capital , a company focused on early-stage therapeutics and energy sustainability. he has brought in hundreds of millions of dollars for various portfolio companies under his leadership. jim plante currently holds more than 50 technology and biotechnical patents and is the founder of the foundation for kidney transplant research. he was also appointed to the industry trade advisory committee on chemicals, pharmaceuticals, health and science products in 2015. richard faragher trustee richard faragher, phd, is a trustee of the biogerontology research foundation, a professor of biogerontology at the university of brighton and past chair of both the british society for research on ageing and the international association of biomedical gerontology. he read biochemistry at imperial college, london and undertook doctoral studies at the university of sussex. his primary research interest is the relationship between cellular senescence and organismal ageing. in 2002 his work on the accelerated ageing disease werner’s syndrome led to the award of the royal pharmaceutical society conference science medal for outstanding scientific achievement. in 2005 he became the first ever scientist to receive a help the aged award for his championship of older people and the use of research for their benefit. in 2010, he became the first ever british recipient of the paul f glenn award for research into the biological mechanisms of the ageing process. he is a visiting professor at the moscow institute of physics and technology and serves on the editorial boards of "age" and "mechanisms of aging and development". professor faraghe

URL analysis for bg-rf.org.uk

http://www.bg-rf.org.uk/press/bgrf-and-sils-scientists-analyze-viability-of-shrna-therapy-for-huntingtons-disease
http://www.bg-rf.org.uk/news
http://www.bg-rf.org.uk/pub-wo/induced-cell-turnover-a-novel-therapeutic-modality-for-in-situ-tissue-regeneration
http://www.bg-rf.org.uk/press/longevity-industry-landscape-overview-volume-ii-the-business-of-longevity
http://www.bg-rf.org.uk/press/longevity-industry-systematized-for-first-time
http://www.bg-rf.org.uk/#part
http://www.bg-rf.org.uk/pub-wo/towards-natural-mimetics-of-metformin-and-rapamycin
http://www.bg-rf.org.uk/podcast
http://www.bg-rf.org.uk/#wwws
http://www.bg-rf.org.uk/pub-wo/converging-blockchain-and-next-generation-artificial-intelligence-technologies-to-decentralize-and-accelerate-biomedical-research-and-healthcare
http://www.bg-rf.org.uk/2018-initiatives
http://www.bg-rf.org.uk/about-us
http://www.bg-rf.org.uk/#latestpub
http://www.bg-rf.org.uk/donate
http://www.bg-rf.org.uk/publications

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Error for "bg-rf.org.uk".

the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 144 seconds

WHOIS lookup made at 02:04:23 24-Oct-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER uk.whois-servers.net

  ARGS bg-rf.org.uk

  PORT 43

  TYPE domain

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED no

DOMAIN

  NAME bg-rf.org.uk

NSERVER

  DNS2.ZONEEDIT.COM 166.88.18.58

  DNS1.ZONEEDIT.COM 31.220.0.12

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .